News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Adnan Bhat, MD

Articles by Adnan Bhat, MD

Unveiling the Potential of Zenocutuzumab: A Breakthrough in NSCLC and Pancreatic Adenocarcinoma Treatment

BySanan Rasheed, MBBS,Umer Farooq, MBBS,Aiman Waheed, MBBS,Musharaf Khalid Bhutta, MBBS,Adnan Bhat, MD,Hamza Nazir, MBBS,Muhammad Hamza Gul, MBBS, MD,Ayesha Aman, MBBS,Zainab Ibrahim, MBBS,Abdul Baseer Wardak, MBBS

August 14th 2025

Zenocutuzumab offers a targeted treatment for NRG1+ lung and pancreatic cancers, demonstrating promising efficacy and manageable adverse effects.

Latest Updated Articles

Unveiling the Potential of Zenocutuzumab: A Breakthrough in NSCLC and Pancreatic Adenocarcinoma Treatment
August 14th 2025

Trending on CancerNetwork

Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC

FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma

The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes

Considering Venlafaxine as Distress Treatment in Breast Cancer

Selinexor Combo Improves Spleen Volume Reduction in Myelofibrosis